EVALUATION OF THE IN VIVO ANTI-HELMINTHIC ACTIVITY, OF BRIDELIA MICRANTHA, CHENOPODIUM AMBROSOIDES AND OCIMUM AMERICANUM EXTRACTS AGAINST SCHISTOSOMA MANSONI INFECTION IN MICE.
- School of Biological Sciences, University of Nairobi, P.O Box 30197-00100, Nairobi .
- The Technical University of Kenya, P.O Box 52428 -00200, Nairobi.
- Institute of Primate Research, P.O. Box 24481-00502, Karen, Nairobi.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Schistosomiasis is a chronic debilitating global disease affecting approximately 600 million people in 74 developing countries, with 800 million, mostly children at risk. Chemotherapy is the only immediate recourse to minimize the prevalence and incidence of this disease worldwide. Presently, Praziquantel is the only drug of choice for the treatment of all forms of schistosomiasis, however it shows low efficacy against schistosomula and juvenile stages. This dependence on a single drug with the likely potential for development of resistance to Praziquantel has justified the search for new alternative chemotherapies. Medicinal plants are potential candidates as sources of new drug prototypes. This study provides findings on the schistosomicidal activity of Bridelia micrantha, Chenopodium ambrosoides and Ocimum americanum plant extracts against Schistosoma mansoni infection in mice. Seven week old BALB/c mice were infected with approximately 250 cercariae and treated on the third and fourth week post infection with five crude extracts from the 3 plants for respective efficacy studies. Praziquantel treated group and infected control group served as controls. Perfusion was performed for all groups on the sixth week after infection for worm recovery. Worm recovery analysis confirmed that the three extracts have antischistosomal properties. Furthermore, pathology showed resolving granulomas and immune profiling results confirmed the extracts had immunomodulatory activity which could potentially be important in inhibiting infection.
- Bourke C, Nausch N, Rujeni N, Appleby LJ, Mitchell K, Midzi N, Mduluza T, Mutapi F. (2013) Integrated Analysis of Innate, Th1, Th2, Th17, and Regulatory Cytokines Identifies Changes in Immune Polarisation Following Treatment of Human Schistosomiasis.?J. Infect. Dis. 208(1):159-169
- Carson FL?(2007) Histotechnology 2nd ed, Chicago: ASCP Press
- Carson FL, Christa H (2009)Histotechnology: A Self-Instructional Text?(3 ed.). Hong Kong:?American Society for Clinical Pathology? pp 2.?
- Cheever AW (1992) Pathogenesis of Schistosoma mansoni Mem.Inst.Oswaldo Cruz 87(4):337-340.
- Cheever AW, Jankovic D,?Yap GS,?Kullberg MC,?Sher A,?Wynn T.A. (1998) Role of cytokines in the formation and downregulation of hepatic circumoval granulomas and hepatic fibrosis in Schistosoma mansoni-infected mice, Mem Inst Oswaldo Cruz 93(1):25-32
- Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA (1999) An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. Clin.Invest 104(6):777-785.
- Chiaramonte MG, Schopf LR, Neben TY, Cheever AW, Donaldson DD, & Wynn TA. (1999) IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni J.Immunol 162(2):920-930.
- Chitsulo L, Engels D, Montresor A, Savioli, L. (2000) The global status of schistosomiasis and its control. Acta Trop 77(1):41-51.
- Cintron-Rivera AA, Diaz-Rivera RS, Garcia-Palmieri MR, Gonzalez O, Koppisch E, Marchand E.J, Ramos-Morales F, Torregrosa MV (1956) Acute Manson's schistosomiasis. J.Med 21(6):918-943.
- Cioli D, Pica-Mattoccia L, Basso A, Guidi A (2014) Schistosomiasis control: praziquantel forever?.?Mol. Biochem. Parasitol?195(1):23-29.
- de Pasquale, A. (1984) Pharmacognosy: the oldest modern science. Ethnopharmacol 11(1):1-16.
- Doenhoff M, Bickle Q, Long E, Bain J, McGregor A (1978) Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. I. Demonstration of resistance to reinfection using a model system that involves perfusion of mice within three weeks of challenge. J. Helminthol 52:173- 186.
- Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN (2000) Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. Immunol 164(5):2585-2591.
- Farah IO, Nyindo M, King CI, Hau J (2000) Hepatic granulomatous response to Schistosoma mansoni eggs in BALB/C mice and Olive baboons (Papiocynocephalus Anubis). J. Comp. Pathol 123:7-14.
- Fenwick A, Savioli L, Engels D, Robert BN, Todd MH (2003) Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 19(11):509-515.
- Flisser A and McLaren DJ (1989) Effect of praziquantel treatment on lung-stage larvae of Schistosoma mansoni in vivo.Parasitol 98(02):203-211.
- Frohberg H (1984) Results of toxicological studies on praziquantel.?Arzneimittel-Forschung,?34(9B), pp.1137-1144
- Gonnert R and Andrews P (1977) Praziquantel, a new board-spectrum antischistosomal agent. Z Parasitenkd 52:129-150.
- Hopwood D (1996) Fixation and fixatives. In: Bancroft J, Stevens A (ed) Theory and practice of histological techniques. New York: Churchill Livingstone
- Ismail M, Botros S, Metwally A, William S, Farghally A, Tao LF, Day TA and Bennett JL (1999) Resistance to Praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. J.Trop.Med.Hyg 60(6):932-935.
- Kabatereine NB, Kemijumbi J, Ouma JH, Sturrock RF, Butterworth AE, Madsen H, ?rnbjerg N, Dunne DW, Vennnervald BJ (2003) Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda.Trans R Soc Trop Med Hyg,?97(5):599-603.
- Katz N, Rocha RS, Chaves A, (1979) Preliminary trials with Praziquantel in human infections due to Schistosoma mansoni. Bull World Health Organ 57:781?785.
- McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis. Clin. Microbiol. Rev 21(1):225-242
- Mitchell K, Mutapi F, Savill N, Woolhouse M (2012)?Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms. Proc Natl Acad Sci U S A 109:13347-13352
- Moilo JM, Mkoji GM, Keriko JM, Yole DS (2014) Anti-Schistosomal activity of Chenopodium ambrosoides extracts in adult worms in vivo and in vitro. Journal of Natural Sciences Research 4:12
- Muchirah PN, Yole D, Kutima H, Waihenya R, Kuria KM, John M (2012) Determination of effective praziquantel dose in different mouse strains: BALB/c and Swiss mice in treatment of Schistosoma mansoni.?J. Clin. Immunol. Immunopathol. Res.,?4(2), pp.12-21.
- Mutapi F,?Burchmore R,?Mduluza T,?Foucher A,?Harcus Y,?Nicoll G,?Midzi N,?Turner CM,?Maizels RM (2005) Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. J Infect Dis 192:1108?1118.
- Nash TE, Cheever AW, Ottesen EA, Cook JA (1982) Schistosome infections in humans: perspectives and recent findings. NIH conference, Intern.Med, 97(5)740-754.
- Nwaka S, Ridley R, (2003) Virtual drug discovery and development for neglected diseases through public private partnerships. Nat. Rev. Drug Discov 2:919-928
- Osebe T, Mbaria J, Yole D, Odongo D, Nderitu J, Ochanda H (2016) Bioactivity and toxicity of Bridelia micrantha, Chenopodium ambrosoides and Ocimum americanum plant extracts.Int J?Basic?Clin Pharmacol 6(1):5-11.
- Ramadan ME, Ramadan MEE, Yousef MSM (2013) Role of TNF alpha in schistosoma mansoni infection and cirrhotic liver, International Journal of Pharmaceutical and Medical Research, 1(1):6-12
- Rates SMK (2001) Plants as source of drugs. Toxicon 39:603-613
- Sabah AA, Fletcher C, Webbe G, Doenhoff MJ (1986) Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 61: 294?303
- Sepulveda J, Tremblay JM, DeGnore JP, Skelly PJ, Shoemaker CB (2010) Schistosoma mansonihost-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats. Int J Parasitol, 40(12): 1407?1417
- Smithers SR, Terry RJ (1965) The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitol 55(4):695-700.
- Tweyongyere R,?Mawa PA,?Kihembo M,?Jones FM,?Webb EL,?Cose S,?Dunne DW,?Vennervald BJ,?Elliott AM (2011) Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on immune responses to schistosome antigens among the offspring: results of a randomised, placebo-controlled trial. BMC Infect Dis 11:234
- van der Werf MJ, De Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, Engels D (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86(2-3):125-139.
- Waiganjo N, Yole D, Ochanda H (2014) Anti-Schistosomal activity of five plant extracts on Swiss white mice infected with Schistosoma mansoni. IOSR J Pharm Biol Sci 9(1):49-53
- Warren KS (1973) The pathology of schistosome infections. Helminth. Abstr. 42:592-633
- WHO (2002) Prevention and Control of Schistosomiasis and Soil-Transmitted Helminthiasis: Report of a WHO Expert Committee. WHO Technical Report Series No. 912 Geneva, Switzerland: World Health Organization.
[Tom Osebe, Dorcas Yole, David Odongo and Horace Ochanda (2018); EVALUATION OF THE IN VIVO ANTI-HELMINTHIC ACTIVITY, OF BRIDELIA MICRANTHA, CHENOPODIUM AMBROSOIDES AND OCIMUM AMERICANUM EXTRACTS AGAINST SCHISTOSOMA MANSONI INFECTION IN MICE. Int. J. of Adv. Res. 6 (Jan). 1097-1108] (ISSN 2320-5407). www.journalijar.com
School of Biological Sciences, University of Nairobi, P.O Box 30197-00100, Nairobi